Frontal Fibrosing Alopecia: A Comprehensive Guide for Cosmetic Dermatologists

Abstract Frontal fibrosing alopecia (FFA) is an inflammatory, scarring hair loss that commonly affects postmenopausal women and presents as frontal hairline recession, facial papules, loss of eyebrows, and facial hyperpigmentation. Because of the chronic, progressive nature of this disease and its i...

Full description

Saved in:
Bibliographic Details
Main Authors: Marina Landau, Sofia M. Perez, Antonella Tosti
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-11-01
Series:Dermatology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s13555-024-01311-z
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Frontal fibrosing alopecia (FFA) is an inflammatory, scarring hair loss that commonly affects postmenopausal women and presents as frontal hairline recession, facial papules, loss of eyebrows, and facial hyperpigmentation. Because of the chronic, progressive nature of this disease and its important impact on aesthetic appearance, patients often consult dermatologists to improve unwanted FFA symptoms. Cosmetic practices including the use of non-ablative lasers, autologous fat injections, and oral isotretinoin can improve FFA-associated facial vein prominence, atrophic indentations, and facial papules, respectively. On the other hand, while exact etiology underlying FFA development remains unclear, some procedures including deep chemical peels and ablative laser therapies have been shown to induce facial scarring and are contraindicated in patients with FFA. In the same way, some cosmetic ingredients can possibly be a triggering or worsening factor for FFA as well. Therefore, it is essential for dermatologists to be aware of both the benefits and risks of cosmetic treatments in patients with diagnosed or suspected FFA. This comprehensive review aims to outline the key cosmetic products and procedures that may be useful in patients with FFA and those which should be considered contraindicated.
ISSN:2193-8210
2190-9172